NCT06482476 Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study
| NCT ID | NCT06482476 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Ioannina |
| Condition | Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students |
| Study Type | OBSERVATIONAL |
| Enrollment | 246 participants |
| Start Date | 2024-06 |
| Primary Completion | 2024-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 246 participants in total. It began in 2024-06 with a primary completion date of 2024-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Data collected will include demographic information, family and medical history, as well as lifestyle habits, and the study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students.
Eligibility Criteria
Inclusion Criteria: * Medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Exclusion Criteria: * Inability/unwillingness to give informed consent
Contact & Investigator
Fotios Barkas, MD, PhD
PRINCIPAL INVESTIGATOR
University of Ioannina
Frequently Asked Questions
Who can join the NCT06482476 clinical trial?
This trial is open to participants of all sexes, studying Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06482476 currently recruiting?
Yes, NCT06482476 is actively recruiting participants. Contact the research team at f.barkas@uoi.gr for enrollment information.
Where is the NCT06482476 trial being conducted?
This trial is being conducted at Ioannina, Greece.
Who is sponsoring the NCT06482476 clinical trial?
NCT06482476 is sponsored by University of Ioannina. The principal investigator is Fotios Barkas, MD, PhD at University of Ioannina. The trial plans to enroll 246 participants.